As essential antibiotics fail, regulator mulls R&D push, curbs on misuse
To address rising threat of antimicrobial resistance, India’s drug regulator plans an overhaul of regulations for antibiotics, including ban on OTC sales, improving tracking of use, and promoting development of new antibiotics, aiming to curb the public health crisis resulting in significant deaths.
To address rising threat of antimicrobial resistance, India’s drug regulator plans an overhaul of regulations for antibiotics, including ban on OTC sales, improving tracking of use, and promoting development of new antibiotics, aiming to curb the public health crisis resulting in significant deaths.
What's Your Reaction?
DDP Editor
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
